Activation of Prodrugs by Antibody-Enzyme Conjugates (Q44184547)

30 November 2017

title

Activation of Prodrugs by Antibody-Enzyme Conjugates (English)

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_12

29 November 2022

author name string

P. D. Senter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1805578

29 November 2022

P. M. Wallace

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1805578

29 November 2022

H. P. Svensson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1805578

29 November 2022

D. E. Kerr

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1805578

29 November 2022

I. Hellstrom

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1805578

29 November 2022

K. E. Hellstrom

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1805578

29 November 2022

language of work or name

English

0 references

publication date

1 January 1991

1 reference

full work available at URL

30 November 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

http://link.springer.com/content/pdf/10.1007/978-1-4684-6000-1_12.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_12

Advances in Experimental Medicine and Biology

29 November 2022

published in

1 reference

30 November 2017

volume

303

1 reference

30 November 2017

page(s)

97-105

1 reference

The First Bagshawe lecture. Towards generating cytotoxic agents at cancer sites

30 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_12

A cytotoxic agent can be generated selectively at cancer sites

29 November 2022

2

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_12

Aryl-2-halogenoalkylamines—XXVI glucuronic, sulphuric and phosphoric esters of p-di-2-chloroethylaminophenol

29 November 2022

4

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_12

Role of the Bp35 cell surface polypeptide in human B-cell activation

29 November 2022

5

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_12

Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamide

29 November 2022

9

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_12

Recent advances with monoclonal antibody drug targeting for the treatment of human cancer

29 November 2022

10

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_12

The linkage of cytotoxic drugs to monoclonal antibodies for the treatment of cancer

29 November 2022

11

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_12

Activation of prodrugs by antibody-enzyme conjugates: a new approach to cancer therapy.

29 November 2022

13

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_12

Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate

29 November 2022

14

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_12

Redesigning nature's poisons to create anti-tumor reagents

29 November 2022

18

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-6000-1_12

29 November 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1805578

29 November 2022

1 reference